{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:35Z","timestamp":1786985435308,"version":"build-2736575974"},"reference-count":86,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bmcl.2019.02.034","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T13:22:03Z","timestamp":1551360123000},"page":"1031-1042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Recent developments in the synthesis and applications of phosphinic peptide analogs"],"prefix":"10.1016","volume":"29","author":[{"given":"Micha\u0142","family":"Talma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ma\u015blanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Mucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.02.034_b0005","first-page":"51","article-title":"Chemical achievement and hope for the future","volume":"36","author":"Pauling","year":"1948","journal-title":"Am Sci"},{"key":"10.1016\/j.bmcl.2019.02.034_b0010","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/223704a0","article-title":"Transition state analogues for enzyme catalysis","volume":"223","author":"Wolfenden","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2019.02.034_b0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1021\/ar00153a003","article-title":"Structural basis of the action of thermolysin and related zinc peptidases","volume":"21","author":"Matthews","year":"1988","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmcl.2019.02.034_b0020","series-title":"Aminophosphonic and Aminophosphinic Acids. Chemistry and Biological Activity","first-page":"407","article-title":"The biological activity of phosphono- and phosphinopeptides","author":"Kafarski","year":"2000"},{"key":"10.1016\/j.bmcl.2019.02.034_b0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/0929867003374831","article-title":"Phosphinic acid compounds in biochemistry, biology and medicine","volume":"7","author":"Collinsov\u00e1","year":"2000","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0030","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2174\/1385272043370177","article-title":"Phosphinic peptides: synthetic approaches and biochemical evaluation as Zn-metalloprotease inhibitors","volume":"8","author":"Yiotakis","year":"2004","journal-title":"Curr Org Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0035","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1021\/jm200587f","article-title":"Remarkable potential of the \u03b1-aminophosphonate\/ phosphinate structural motif in medicinal chemistry","volume":"54","author":"Mucha","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0040","first-page":"1713530","article-title":"Synthesis and modifications of phosphinic dipeptide analogues","author":"Mucha","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2019.02.034_b0045","first-page":"1","article-title":"Phosphinic peptides as potent inhibitors of zinc-metalloproteases","volume":"360","author":"Georgiadis","year":"2015","journal-title":"Top Curr Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0050","doi-asserted-by":"crossref","first-page":"e1141","DOI":"10.3390\/molecules21091141","article-title":"Stereoselective synthesis of \u03b1-amino-C-phosphinic acids and derivatives","volume":"21","author":"Viveros-Ceballos","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2019.02.034_b0055","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.tetlet.2010.03.020","article-title":"New opinions on the amidoalkylation of hydrophosphorylic compounds","volume":"51","author":"Dmitriev","year":"2010","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2019.02.034_b0060","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.tetlet.2012.01.094","article-title":"Arbuzov-type reaction of acylphosphonites and N-alkoxycarbonylimine cations generated in situ with trifluoroacetic anhydride","volume":"53","author":"Dmitriev","year":"2012","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2019.02.034_b0065","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1134\/S1070363216120276","article-title":"Synthesis of pseudoalanylalanine","volume":"86","author":"Vinyukov","year":"2016","journal-title":"Russ J Gen Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0070","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1134\/S1070363215090121","article-title":"Synthesis of phosphorus isosters of \u03b2-amyloid peptides fragments","volume":"85","author":"Dmitriev","year":"2015","journal-title":"Russ J Gen Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0075","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1134\/S1070363215090315","article-title":"Synthesis of pseudo-methionyl-glutamate","volume":"85","author":"Dmitriev","year":"2015","journal-title":"Russ J Gen Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0080","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1134\/S1070363217020189","article-title":"Synthesis of P, N-protected phosphinic pseudoprolylglycine block","volume":"87","author":"Vinyukov","year":"2017","journal-title":"Russ J Gen Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0085","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1016\/j.bmcl.2013.05.069","article-title":"Phosphinic acid-based inhibitors of tubulin polyglutamylases","volume":"23","author":"Liu","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.02.034_b0090","doi-asserted-by":"crossref","first-page":"17163","DOI":"10.1074\/jbc.R115.637447","article-title":"Writing and reading the tubulin code","author":"Yu","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0095","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1021\/acschembio.5b01039","article-title":"A bacterial cell shape-determining inhibitor","volume":"11","author":"Liu","year":"2016","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2019.02.034_b0100","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1107\/S1399004714018732","article-title":"Structural basis for the recognition of muramyltripeptide by Helicobacter pylori Csd4, a D, L-carboxypeptidase controlling the helical cell shape","volume":"70","author":"Kim","year":"2014","journal-title":"Acta Crystallogr Sect D Biol Crystallogr"},{"key":"10.1016\/j.bmcl.2019.02.034_b0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3998\/ark.5550190.p009.067","article-title":"Synthesis of dipeptide mimics based on amino phosphinate backbones and cyclic derivatives","author":"R\u00fcping","year":"2015","journal-title":"Arkivoc"},{"key":"10.1016\/j.bmcl.2019.02.034_b0110","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2174\/092986712799462658","article-title":"Structure-activity relationships of glutamate carboxypeptidase II (GCPII) inhibitors","volume":"19","author":"Ferraris","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0115","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm030795v","article-title":"The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity","volume":"46","author":"Grembecka","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0120","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1073\/pnas.0807398106","article-title":"Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase","volume":"106","author":"McGowan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2019.02.034_b0125","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.biochi.2012.10.018","article-title":"An integrated approach to the ligand binding specificity of Neisseria meningitidis M1 alanine aminopeptidase by fluorogenic substrate profiling, inhibitory studies and molecular modeling","volume":"95","author":"W\u0119glarz-Tomczak","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.bmcl.2019.02.034_b0130","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1021\/jm501071f","article-title":"Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases","volume":"57","author":"Vassiliou","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejmech.2016.04.018","article-title":"A structural insight into the P1\u2013S1 binding mode of diaminoethylphosphonic and phosphinic acids, selective inhibitors of alanine aminopeptidases","volume":"117","author":"W\u0119glarz-Tomczak","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0140","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1016\/j.bmcl.2016.06.062","article-title":"Discovery of potent and selective inhibitors of human aminopeptidases ERAP1 and ERAP2 by screening libraries of phosphorus-containing amino acid and dipeptide analogues","volume":"26","author":"W\u0119glarz-Tomczak","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.02.034_b0145","doi-asserted-by":"crossref","first-page":"10069","DOI":"10.1021\/jo401084v","article-title":"Mapping the pathway toward thiophosphinic pseudopeptides. Synthesis of suitably protected PG-Phe-\u03a8[P(S)(OX)CH2]-Gly-OY analogues as thiophosphinyl dipeptide isosters (TDI), a comparative study for selective deprotection and further elongation","volume":"78","author":"Vassiliou","year":"2013","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0150","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1021\/jm100340m","article-title":"Computer-aided optimization of phosphinic inhibitors of bacterial ureases","volume":"53","author":"Vassiliou","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0155","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1002\/chem.200903281","article-title":"A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography","volume":"16","author":"Notni","year":"2010","journal-title":"Chem Eur J"},{"key":"10.1016\/j.bmcl.2019.02.034_b0160","doi-asserted-by":"crossref","first-page":"14718","DOI":"10.1002\/chem.201103503","article-title":"TRAP, a powerful and versatile framework for gallium-68 radiopharmaceuticals","volume":"17","author":"Notni","year":"2011","journal-title":"Chem Eur J"},{"key":"10.1016\/j.bmcl.2019.02.034_b0165","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/cmdc.201200261","article-title":"A monoreactive bifunctional triazacyclononane phosphinate chelator with high selectivity for gallium-68","volume":"7","author":"Sime\u010dek","year":"2012","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0170","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1002\/chem.201300338","article-title":"A cyclen-based tetraphosphinate chelator for the preparation of radiolabeled tetrameric bioconjugates","volume":"19","author":"Sime\u010dek","year":"2013","journal-title":"Chem Eur J"},{"key":"10.1016\/j.bmcl.2019.02.034_b0175","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/cmdc.201400055","article-title":"Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications","volume":"9","author":"Notni","year":"2014","journal-title":"Chem Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0180","doi-asserted-by":"crossref","first-page":"13112","DOI":"10.3390\/molecules200713112","article-title":"The influence of the combination of carboxylate and phosphinate pendant arms in 1,4,7-triazacyclononane-based chelators on their 68Ga labelling properties","volume":"20","author":"M\u00e1t\u00e9","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2019.02.034_b0185","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1021\/bc200227d","article-title":"Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: signal amplification via multivalency","volume":"22","author":"Singh","year":"2011","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cmmi.232","article-title":"68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals","volume":"3","author":"Fani","year":"2008","journal-title":"Contrast Media Mol Imag"},{"key":"10.1016\/j.bmcl.2019.02.034_b0195","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1016\/j.bmc.2015.11.024","article-title":"Development of 68Ga-labeled multivalent nitroimidazole derivatives for hypoxia imaging","volume":"23","author":"Seelam","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2191-219X-2-28","article-title":"Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET","volume":"2","author":"Notni","year":"2012","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.bmcl.2019.02.034_b0205","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/mp5000746","article-title":"Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of 68Ga-NOPO-c(RGDfK)","volume":"11","author":"Sime\u010dek","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2019.02.034_b0210","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1021\/mp400642s","article-title":"Tailored gallium(III) chelator NOPO: synthesis, characterization, bioconjugation, and application in preclinical Ga-68-PET imaging","volume":"11","author":"Sime\u010dek","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2019.02.034_b0215","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1021\/acsomega.8b00035","article-title":"Therapeutic radiopharmaceuticals targeting integrin \u03b1v\u03b26","volume":"3","author":"F\u00e4rber","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmcl.2019.02.034_b0220","doi-asserted-by":"crossref","first-page":"11137","DOI":"10.1039\/C5DT00576K","article-title":"A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform","volume":"44","author":"Baranyai","year":"2015","journal-title":"Dalton Trans"},{"key":"10.1016\/j.bmcl.2019.02.034_b0225","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1021\/acs.molpharmaceut.8b00602","article-title":"Molar activity of Ga-68 labeled PSMA inhibitor conjugates determines PET imaging results","volume":"15","author":"Wurzer","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmcl.2019.02.034_b0230","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1039\/C6CC10169K","article-title":"Dendritic poly-chelator frameworks for multimeric bioconjugation","volume":"53","author":"Reich","year":"2017","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmcl.2019.02.034_b0235","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/chem.201702335","article-title":"Dual-nuclide radiopharmaceuticals for positron emission tomography based dosimetry in radiotherapy","volume":"24","author":"Wurzer","year":"2018","journal-title":"Chem Eur J"},{"key":"10.1016\/j.bmcl.2019.02.034_b0240","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1021\/jo9603439","article-title":"Protection of the hydroxyphosphinyl function of phosphinic dipeptides by adamantyl. Application to the solid-phase synthesis of phosphinic peptides","volume":"61","author":"Yiotakis","year":"1996","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0245","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10989-012-9307-y","article-title":"Synthesis of Fmoc-Gly-Ile phosphinic pseudodipeptide: residue specific conditions for construction of matrix metalloproteinase inhibitor building blocks","volume":"18","author":"Bhowmick","year":"2012","journal-title":"Int J Pept Res Ther"},{"key":"10.1016\/j.bmcl.2019.02.034_b0250","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/med.20066","article-title":"Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors","volume":"27","author":"Matziari","year":"2007","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmcl.2019.02.034_b0255","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.mam.2008.06.001","article-title":"Synthetic active site-directed inhibitors of metzincins: achievement and perspectives","volume":"29","author":"Yiotakis","year":"2008","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.bmcl.2019.02.034_b0260","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1073\/pnas.96.8.4330","article-title":"RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites","volume":"96","author":"Dive","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2019.02.034_b0265","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1021\/jm9900164","article-title":"Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study","volume":"42","author":"Vassiliou","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0270","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1021\/jm990483l","article-title":"Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and antinociceptive activities","volume":"43","author":"Chen","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0275","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/HYPERTENSIONAHA.107.097865","article-title":"Angiotensin-converting enzyme C-terminal catalytic domain is the main site of angiotensin I cleavage in vivo","volume":"51","author":"Fuchs","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.bmcl.2019.02.034_b0280","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-3565(24)29576-8","article-title":"RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis","volume":"297","author":"Junot","year":"2001","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.bmcl.2019.02.034_b0285","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1021\/jm9010803","article-title":"Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors","volume":"53","author":"Jullien","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/BJ20102123","article-title":"Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide","volume":"436","author":"Akif","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.bmcl.2019.02.034_b0295","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/febs.12660","article-title":"Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzyme","volume":"281","author":"Masuyer","year":"2014","journal-title":"FEBS J"},{"key":"10.1016\/j.bmcl.2019.02.034_b0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/CS20130403","article-title":"Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors","volume":"126","author":"Douglas","year":"2014","journal-title":"Clin Sci"},{"key":"10.1016\/j.bmcl.2019.02.034_b0305","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1111\/febs.13900","article-title":"The influence of angiotensin converting enzyme mutations on the kinetics and dynamics of N-domain selective inhibition","volume":"283","author":"Lubbe","year":"2016","journal-title":"FEBS J"},{"key":"10.1016\/j.bmcl.2019.02.034_b0310","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2019.02.034_b0315","doi-asserted-by":"crossref","first-page":"11152","DOI":"10.1074\/jbc.M600222200","article-title":"Development of selective inhibitors and substrate of matrix metalloproteinase-12","volume":"281","author":"Devel","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0320","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1021\/jm301574d","article-title":"Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies","volume":"56","author":"Czarny","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0325","doi-asserted-by":"crossref","first-page":"10408","DOI":"10.1021\/ja0715849","article-title":"Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors","volume":"129","author":"Lauer-Fields","year":"2007","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2019.02.034_b0330","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cbic.201402716","article-title":"Matrix metalloproteinase inhibition by heterotrimeric triplehelical peptide transition state analogs","volume":"16","author":"Bhowmick","year":"2015","journal-title":"Chem Bio Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0335","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/acs.jmedchem.7b00018","article-title":"Second generation triple-helical peptide inhibitors of matrix metalloproteinases","volume":"60","author":"Bhowmick","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0340","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coi.2012.10.001","article-title":"Peptidases trimming MHC class I ligands","volume":"25","author":"Weimershaus","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.bmcl.2019.02.034_b0345","doi-asserted-by":"crossref","first-page":"19890","DOI":"10.1073\/pnas.1309781110","article-title":"Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses","volume":"110","author":"Zervoudi","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2019.02.034_b0350","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.1021\/acs.jmedchem.6b01031","article-title":"Optimization and structure-activity relationships of phosphinic pseudotripeptide inhibitors of aminopeptidases that generate antigenic peptides","volume":"59","author":"Kokkala","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0355","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1021\/acs.jmedchem.6b01890","article-title":"Ligand-induced conformational change of insulin-regulated aminopeptidase: insights on catalytic mechanism and active site plasticity","volume":"60","author":"Mpakali","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0360","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.4049\/jimmunol.1501103","article-title":"Crystal structure of insulin-regulated aminopeptidase with bound substrate analogue provides insight on antigenic epitope precursor recognition and processing","volume":"195","author":"Mpakali","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.bmcl.2019.02.034_b0365","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ab.2013.06.016","article-title":"A sensitive fluorigenic substrate for selective in vitro and in vivo assay of leukotriene A4 hydrolase activity","volume":"441","author":"Poras","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0370","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1002\/anie.200604408","article-title":"Cross-linking yield variation of a potent matrix metalloproteinase photoaffinity probe and consequences for functional proteomics","volume":"46","author":"David","year":"2007","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2019.02.034_b0375","doi-asserted-by":"crossref","first-page":"31058","DOI":"10.1074\/jbc.M805795200","article-title":"Molecular determinants of matrix metalloproteinase-12 covalent modification by a photoaffinity probe","volume":"283","author":"Dabert-Gay","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0380","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cbic.201200583","article-title":"A pan photoaffinity probe for detecting active forms of matrix metalloproteinases","volume":"14","author":"Nury","year":"2013","journal-title":"Chem Bio Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0385","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/pr801069c","article-title":"Detection of matrix metalloproteinase active forms in complex proteomes: evaluation of affinity versus photoaffinity capture","volume":"8","author":"Bregant","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.bmcl.2019.02.034_b0390","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1021\/acs.bioconjchem.6b00377","article-title":"Synthesis, in vitro and in vivo evaluation of MMP-12 selective optical probes","volume":"27","author":"Bordenave","year":"2016","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0395","doi-asserted-by":"crossref","first-page":"38345","DOI":"10.1038\/srep38345","article-title":"Optical imaging of MMP-12 active form in inflammation and aneurysm","volume":"6","author":"Razavian","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2019.02.034_b0400","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/art.38295","article-title":"In vivo imaging of matrix metalloproteinase 12 and matrix metalloproteinase 13 activities in the mouse model of collagen-induced arthritis","volume":"66","author":"Lim","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.bmcl.2019.02.034_b0405","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1002\/chem.201405626","article-title":"Probing the mechanism of allylic substitution of Morita-Baylis-Hillman acetates (MBHAs) by using the silyl phosphonite paradigm: Scope and applications of a versatile transformation","volume":"21","author":"Kalyva","year":"2015","journal-title":"Chem Eur J"},{"key":"10.1016\/j.bmcl.2019.02.034_b0410","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1021\/jm0308491","article-title":"Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11","volume":"47","author":"Matziari","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.02.034_b0415","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/ATVBAHA.110.219147","article-title":"A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice","volume":"31","author":"Johnson","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bmcl.2019.02.034_b0420","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nm.3508","article-title":"A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity","volume":"20","author":"Marchant","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.bmcl.2019.02.034_b0425","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.116","article-title":"Long lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain","volume":"3","author":"Bonnard","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.bmcl.2019.02.034_b0430","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/2211-5463.12540","article-title":"Inhibitors of BMP-1\/tolloid-like proteinases: efficacy, selectivity and cellular toxicity","volume":"8","author":"Talantikite","year":"2018","journal-title":"FEBS Open Bio"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19301179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19301179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:28:34Z","timestamp":1760772514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19301179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":86,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0960894X19301179"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.02.034","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent developments in the synthesis and applications of phosphinic peptide analogs","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.02.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}